Verification evidence is still being completed.
Hummingbird Diagnostics
Heidelberg, Germany
- Verified lead
- Tillman Weiss
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- Chief Executive Officer
- 2026 technical specialization
- Molecular Diagnostics, miRNA Biomarkers, Liquid Biopsy, Oncology, and Neurology
- Review cycle
- May 2026
- Full address
- Im Neuenheimer Feld 583, 69120 Heidelberg, Germany
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official Hummingbird Diagnostics news page confirming the Heidelberg address.
- Editorial note
- Hummingbird Diagnostics is published because official company materials confirm current leadership, Heidelberg operating address, and a real molecular-diagnostics platform.
Molecular Diagnostics, miRNA Biomarkers, Liquid Biopsy, Oncology, and Neurology
Official leadership disclosure, Official Heidelberg address disclosure, Diagnostics platform claim
Hummingbird Diagnostics is published because official company materials confirm current leadership, Heidelberg operating address, and a real molecular-diagnostics platform.
Hummingbird Diagnostics
Molecular Diagnostics, miRNA Biomarkers, Liquid Biopsy, Oncology, and Neurology · Diagnostics platform
Hummingbird Diagnostics runs biomarker diagnostics development, liquid-biopsy programs, and molecular testing platform work in Heidelberg, Germany.
- Lead
- Tillman Weiss (verified ↗)
- Address
- Im Neuenheimer Feld 583, 69120 Heidelberg, Germany (source ↗)
- Compliance
- Not yet on record
- Last reviewed
- 22 Mar 2026 (2mo ago)
- Scale
- Diagnostics platform
- Capabilities
- Biomarker Diagnostics Development · Liquid-Biopsy Programs · Molecular Testing Platform Work
- Founded
- 2008
- Headcount
- 11-50
- Company page (open ↗)
Tillman Weiss
Chief Executive Officer
Official Hummingbird Diagnostics materials listing the Heidelberg address.
Open sourceDiagnostics platform
Heidelberg, Germany. Molecular Diagnostics, miRNA Biomarkers, Liquid Biopsy, Oncology, and Neurology. Review completed on 22 Mar 2026.
German molecular-diagnostics oversight
Official leadership disclosure, Official Heidelberg address disclosure, Diagnostics platform claim
Molecular Diagnostics, miRNA Biomarkers, Liquid Biopsy, Oncology, and Neurology
Hummingbird Diagnostics is published because official company materials confirm current leadership, Heidelberg operating address, and a real molecular-diagnostics platform.
Hummingbird Diagnostics is published because official company materials confirm current leadership, Heidelberg operating address, and a real molecular-diagnostics platform.
Core capabilities
Primary declared technical activities and areas of operating focus.
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Declared infrastructure
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Frequently asked questions
- Where is Hummingbird Diagnostics located?
- Hummingbird Diagnostics operates from Im Neuenheimer Feld 583, 69120 Heidelberg, Germany, Heidelberg, Germany.
- Who runs Hummingbird Diagnostics?
- Hummingbird Diagnostics is led by Tillman Weiss, Chief Executive Officer. Verified 22 Mar 2026.
- What does Hummingbird Diagnostics do?
- Hummingbird Diagnostics runs biomarker diagnostics development, liquid-biopsy programs, and molecular testing platform work in Heidelberg, Germany. Core capabilities: Biomarker Diagnostics Development, Liquid-Biopsy Programs, Molecular Testing Platform Work.
Related technical briefs
Briefs that name Heidelberg as a covered market or city.
